Arya Sciences Acquisition Corp. II (NYSE:ARYB) announced in an 8-K filing that it has secured shareholder approval for its business combination with biotech company Crevel Therapeutics in a vote held earlier today.
The parties expect to close this transaction October 27 and the shares and warrants of the combined entity are set to begin trading Wednesday, October 28 under the ticker symbols “CERE” and “CEREW,” respectively.
Shares representing 74.78% of the company’s total took part and approved all proposals by wide margins. However, about 15% of shares voted against proposals allowing the combined entity’s board to issue new preferred shares and removing the ability of shareholders to take action via written consent rather than an approved meeting. The filing did not disclose redemption figures.
Arya Sciences II announced its $847 million business combination with Cerevel on July 30. Cerevel is developing a variety of potential treatments for neurological diseases.
For a description all of the proposals voted on at the special meeting, click HERE.
The SPAC boom of 2020-2021 brought the asset class into sectors they had never entered before and that had generated few if any public companies of any kind. Space was one of these, but it appeared to be a passing fascination as soon as macro financial winds changed. That could be about to change once...
At the SPAC of Dawn As portions of the market rallied suddenly yesterday from Wednesday’s inflation gloom, LiveWire (NYSE:LVWR) was among the surprising gainers. The manufacturer of electric motorcycles that spun out from Harley Davidson in a 2022 SPAC deal with AEA-Bridges has never been among the flashiest EV de-SPACs, but it has quietly provided...
SPACs have brought a number of sustainability companies to market, but the economics of carbon credits have always been on the edge of those specific opportunities. Focus Impact Acquisition Corp. (NASDAQ:FIAC) aims to change that with its $213 million combination with DevvStream, a Canadian company focused on generating carbon credits with proprietary technology-based approaches. This week, we...
At the SPAC of Dawn Yesterday’s high CPI readings may have dampened hopes of summer rate cuts, but the public markets do seem increasingly content to shoot towards the cosmos in terms of the new types of companies they hope to welcome. SPACs have been a major part of commercial space ventures accessing public capital,...
In a surprise move, the NYSE has proposed a rule change to its listing standards to allow SPACs to continue listing up to an additional six months beyond the current 36. However, this is only if the SPAC has signed a definitive agreement prior to the 36 month deadline. As background, both the Nasdaq and...